Canada Life’s Akcea Therapeutics Inc AKCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-1,094
Closed -$20K 2696
2020
Q3
$20K Hold
1,094
﹤0.01% 2450
2020
Q2
$15K Hold
1,094
﹤0.01% 2543
2020
Q1
$16K Hold
1,094
﹤0.01% 2437
2019
Q4
$18K Buy
+1,094
New +$20.4K ﹤0.01% 2522
2019
Q3
Sell
-2,062
Closed -$48K 2634
2019
Q2
$48K Hold
2,062
﹤0.01% 2454
2019
Q1
$58K Hold
2,062
﹤0.01% 2227
2018
Q4
$60K Hold
2,062
﹤0.01% 2311
2018
Q3
$72K Hold
2,062
﹤0.01% 2301
2018
Q2
$49K Hold
2,062
﹤0.01% 2408
2018
Q1
$53K Hold
2,062
﹤0.01% 2353
2017
Q4
$36K Buy
+2,062
New +$40.4K ﹤0.01% 2427

Canada Life's AKCA Position: Q4 2020 in Review

Canada Life sold out of Akcea Therapeutics Inc (AKCA) in Q4 2020, closing a stake of 1,094 shares — an estimated $20K sold.

Canada Life first reported a position in AKCA in Q4 2017 and held it in 11 quarters. The position peaked at $72K in Q3 2018. 0 funds tracked by Wall St. Rank hold AKCA as of Q4 2020.

  • Canada Life reported no remaining Akcea Therapeutics Inc position as of Q4 2020 after selling out during the quarter.
  • Canada Life sold 1,094 Akcea Therapeutics Inc shares in Q4 2020, an estimated $20K.
  • Canada Life first reported a position in Akcea Therapeutics Inc in Q4 2017 and held it in 11 quarters.
  • Canada Life's Akcea Therapeutics Inc position peaked at $72K in Q3 2018.
  • 0 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q4 2020.

Based on Canada Life's 13F filing for Q4 2020, filed 16 Feb 2021.